BioCentury
ARTICLE | Clinical News

Stalevo levodopa/carbidopa/entacapone: Started Phase III

November 1, 2004 8:00 AM UTC

The partners began the 2-year, double-blind, international Phase III STRIDE-PD trial in about 740 patients comparing Stalevo to a traditional formulation of levodopa/carbidopa. ...